IL6 and pancreatic neoplasm: A human pancreatic cancer (PC) cell, Capan‐1, was confirmed to have the stimulant activity of IL‐6/gp130 axis through the evaluation of mRNA, cell surface protein and intracellular protein levels and chemotaxis and wound healing assay.